Delcath Systems Inc (DCTH)

[Rapture2020]

I never would have invested in DCTH until it was within 12-16 months of FDA approval. What would have been the incentive in 2014, 2015, 2016, and 2017 as they were snaking their way through the FDA clinical trials? That’s like watching paint dry, IMO. DCTH had only one clinical trial over a 4 year period and only recently has their been a 2nd (ICC).

I suspect many folks didn’t sell after that massive 1,000% run in 2017 and saw profits evaporate. Then came the two reverse splits. I understand why people are hot under the collar.

I wonder if things would have been different had shareholders voted to give her the RS last August? I think so.

It’s June 2018 with a new deal keeping them going. A deal without massive dilution—as she said wouldn’t happen again. This deal works for me.

I don’t often agree with Sam (setting aside for a moment this will be twice in one day), but it’s crystal clear this is Jenny’s show until approval.